Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N'-nitro-N-nitrosoguanidine-induced mutation, transformation, and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes.
- 1 December 1992
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (23) , 11199-11203
- https://doi.org/10.1073/pnas.89.23.11199
Abstract
While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphosphotriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N9-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 10(6) cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 10(6) cells when treated with MNNG at 0.4 micrograms/ml. Protection against mutagenesis by MNNG at 0.8 micrograms/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 10(6) cells. As an MNNG dose of 0.6 micrograms/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 micrograms/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 micrograms/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.Keywords
This publication has 33 references indexed in Scilit:
- Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanineCarcinogenesis: Integrative Cancer Research, 1991
- Site-specific mutagenesis: retrospective and prospectiveCarcinogenesis: Integrative Cancer Research, 1991
- Isolation and cDNA cloning of a rat; O6-alkyllguanine-DNA-alkyltransferase gene, molecelar analysis of expression in rat liverCarcinogenesis: Integrative Cancer Research, 1991
- The role of O6-alkylguanine in cell killing and mutagenesis in Chinese hamster ovary cellsCarcinogenesis: Integrative Cancer Research, 1991
- The E. coli ogt geneMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- ras oncogenes: their role in neoplasiaEuropean Journal of Clinical Investigation, 1990
- Activation of the Ha-ras gene in C3H 10T1/2 cells transformed by exposure to N-methyl-N′-nitro-N-nitrosoguanidineBiochemical and Biophysical Research Communications, 1987
- Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutationsNature, 1983
- Improved transformation of C3H10T1/2CL8 cells by direct- and indirect-acting carcinogensCarcinogenesis: Integrative Cancer Research, 1982
- Further evidence that ouabain-resistant variants induced by chemical carcinogens in transformable C3H/10T1/2 Cl 8 mouse fibroblasts are mutantsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1980